AI help for eye disease decisions
Part of Eyes & vision clinical trials.
This trial uses artificial intelligence to help doctors make better decisions about eye disease. It analyzes your medical records and images to see how AI can improve care and track disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were treated for an eye condition at one of the listed hospitals.
- Your hospital records include eye images like photos of the back of your eye, and notes or test results.
- You have a clear diagnosis of one or more eye diseases.
- You have follow-up records that show how your eye condition changed over time.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how artificial intelligence can help doctors make better decisions about eye diseases. It may be a good fit if you have an eye condition and can share your medical records and images.
This trial tests a new artificial intelligence system that helps eye doctors make decisions. You may qualify if you are having a routine eye exam and can get clear images of both eyes.
This trial uses artificial intelligence to analyze eye images and help diagnose and prioritize eye conditions. It could help find the right treatment faster.
This trial tests an artificial intelligence (AI) tool that uses eye images to help doctors diagnose breathing or lung-related conditions. If you have a lung/breathing problem and can do both eye and lung checkups, it may support faster or more accurate diagnosis.
This trial uses artificial intelligence to analyze eye images and help doctors diagnose eye diseases. It looks at images from routine care to train and test the AI system.
This trial uses a smart computer system to help diagnose multiple eye diseases by looking at your eye scans. You may qualify if you have one of the listed eye conditions and your scans are clear enough for the AI to analyze.
Hear when a new Ocular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.